FRE

FIREBRICK FPO [FRE]
Firebrick Pharma Limited develops and commercializes povidone-iodine (PVP-I) products under the Nasodine brand in Asia, North America, Europe, and internationally. It offers nasal and throat spray PVP-I products for the treatment of common cold. The company was incorporated in 2012 and is based in Melbourne, Australia.
Healthcare · ASX Small Cap
$0.0300 +3.4%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when FRE triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track FRE — Free

Active Signals

Bullish Signals

  • MACD momentum is losing steam
  • Stochastic just turned bullish from a low level — early reversal sign
  • Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
  • Drifting lower — down 6.3% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.14, so it's outpacing the pack
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Low cash runway (2 quarters) - dilution risk
  • Very high P/S ratio (63.5x)
  • Revenue in sharp decline (-86%)
  • Near 52-week low (12% of range)
  • Micro-cap ($5-20M) - high risk
  • Capital raise activity (1 events)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 56% over the past year
  • Altman Z-Score distress zone (1.00 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.030)
  • Beneish M-Score 11.21 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -86% — the top line is shrinking
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.93%/day)

Expected next for FRE

3 Nov 2026Quarterly Cash Flow Report (4C)Estimated from past filings
Window: 27 Oct to 10 Nov
The last 6 moved FRE +2.0% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Appendix 4G
NONE Corporate Governance Statement
NONE Cleansing Notice
LOW Appendix 4E and Annual Report 30 June 2026

Recent ASX Announcements

2026-08-31 Appendix 4G
2026-08-31 Corporate Governance Statement
2026-08-31 Appendix 4E and Annual Report 30 June 2026 PRICE SENSITIVE
2026-08-10 Cleansing Notice
2026-08-10 Application for quotation of securities - FRE

Key Metrics

$8.6M
Market Cap
147K
Avg Volume
0.6x
Vol Ratio
$0.02 — $0.07
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-189.2%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 56%
LLeader vs LaggardlaggardRS: -15
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:FRE vs NUZFRE vs IPDFRE vs HIQ
Share this analysis

Track FRE and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required